Is there a real advantage in utilizing central venous ports in oncology surgery? An analysis of the cost-effectiveness ratio

Tumori

Volumn 87, Issue 4, 2001, Pages

  Biffi, R ^a   Pozzi, S ^a   Pace, U ^a   Cenciarelli, S ^a   Zambelli, M ^a   Orsi, F ^a   Grasso, R F ^a   De Braud, F ^a   Andreoni, B ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CENTRAL VENOUS CATHETER; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; HUMAN; ONCOLOGY; PALLIATIVE THERAPY; PATIENT CARE;

EID: 0034804616     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700438     Document Type: Conference Paper

References (9)

1. Long term, totally implantable central venous access ports connected to Groshong catheter for chemotherapy of solid tumours: Experience on 178 cases using a single type of device
2. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days
3. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life
4. Outpatient percutaneous central venous access in cancer patients
5. Experience with subcutaneous infusion ports in three hundred patients
6. Long term experience with a totally implanted catheter system in gynecologic oncologic patients
7. A case-control comparison of durability and cost between implanted reservoir and percutaneous catheters in cancer patients
8. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients
9. Vascular access options for outpatient cancer therapy